ERT study indicates swift adoption of virtual clinical trials due to COVID-19
PHILADELPHIA – ERT, the global leader in clinical endpoints data collection, announced the results of a recent industry survey that indicate an acceleration in the adoption of virtual clinical trials due to the COVID-19 pandemic. According to the survey report, ‘Virtual Trials and the COVID-19 Pandemic: The State of the Industry,” 82% of clinical trial
